VeriTeQ to sell long-approved microchip for wireless tracking of breast implants
VeriTeQ has announced plans to market VeriChip, its passive radiofrequency identification (RFID) microchip, for identifying and tracing the whereabouts of breast implants.
In announcing the offering, the Delray Beach, Fla.-based manufacturer said it believes the 8-millimeter microchip can also be used safely and effectively in artificial joint replacements.
VeriTeQ said the FDA cleared the VeriChip for sale in 2004. The company did not explain the eight-year lag between approval and availability.
In announcing the offering, the Delray Beach, Fla.-based manufacturer said it believes the 8-millimeter microchip can also be used safely and effectively in artificial joint replacements.
VeriTeQ said the FDA cleared the VeriChip for sale in 2004. The company did not explain the eight-year lag between approval and availability.
Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.